Competitive intelligence on
small-molecule drugs and
the 90,000 global patents
|Title:||Intravaginal treatment of vaginal infections with buffered metronidazole compositions|
|Abstract:||A non-flowing composition and method for treatment of bacterial vaginosis are disclosed. An afflicted vagina is treated with a therapeutically effective but relatively low dose of metronidazole in a composition that includes a buffer system maintaining the composition at a pH value in the range of about 3.75 to about 4.25. The composition can also be used for prophylactic purposes.|
|Inventor(s):||Borgman; Robert J. (Mundelein, IL)|
|Assignee:||Curatek Pharmaceuticals Limited Partnership (Elk Grove Village, IL)|
Patent Claim Types:|
see list of patent claims
|Use; Composition; Dosage form;|
|Country||Document Number||Publication Date|
|World Intellectual Property Organization (WIPO)||9014832||Dec 13, 1990|
|World Intellectual Property Organization (WIPO)||8906537||Jul 27, 1989|
|Israel||94619||Apr 15, 1991|
|United States of America||5840744||Nov 24, 1998|
|Ireland||65413||Oct 18, 1995|
|This preview shows a limited data set|
Subscribe for full access, or try a free trial
Export unavailable in trial.
Subscribe for complete access.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.